Report cover image

Animal Model Market Size, Share & Trends Analysis Report By Animal Type (Mice, Guinea Pigs), By Application (Cancer, Infectious Disease), By End Use, By Region, And Segment Forecasts, 2025 - 2033

Publisher Grand View Research
Published Nov 04, 2025
Length 150 Pages
SKU # GV20649458

Description

Animal Model Market Summary

The global animal model market size was estimated at USD 2.42 billion in 2024 and is projected to reach USD 5.18 billion by 2033, growing at a CAGR of 8.94% from 2025 to 2033. The increasing use of animal models in biomedical, neurological, genetic, toxicology, and cancer research is driving global market growth.

Moreover, growing R&D efforts by biopharmaceutical companies to develop novel therapeutics and the emergence of advanced technologies, such as CRISPR, in biomedical research, are other factors contributing to industry expansion.

Global Animal Model Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global animal model market based on animal type, application, end use, and region:
  • Animal Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Mice
  • Rat
  • Guinea Pigs
  • Rabbits
  • Hamsters
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Cancer
  • Immunological Disease
  • Infectious Disease
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical & Biotechnology Companies
  • Academic Research Institute
  • Contract Research Organization
  • Regional Outlook (Revenue, USD Million, 2021- 2033)
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Thailand
  • South Korea
  • Latin America
  • Brazil
  • Argentina
  • Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
Please note The report will be delivered in 2-3 business days upon order notification.

Table of Contents

150 Pages
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Segment Definitions
1.1.1.1. Animal Type Segment
1.1.1.2. Application Segment
1.1.1.3. End Use Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objective
1.4.1. Objective 1
1.4.2. Objective2
1.4.3. Objective 3
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. GVR’s Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information or Data Analysis:
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.10. List of Secondary Sources
1.11. List of Abbreviations
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing Prevalence of Chronic and Lifestyle Diseases
3.2.1.2. Preclinical Research Needs
3.2.2. Market Restraint Analysis
3.2.2.1. High cost of process
3.2.2.2. Stringent rules pertaining to animal testing.
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
Chapter 4. Animal Type Business Analysis
4.1. Animal Model Market: Animal Type Movement Analysis
4.2. Mice
4.2.1. Mice Market, 2021 - 2033 (USD Million)
4.3. Rat
4.3.1. Rat Market, 2021 - 2033 (USD Million)
4.4. Guinea Pig
4.4.1. Guinea Pig Market, 2021 - 2033 (USD Million)
4.5. Rabbits
4.5.1. Rabbits Market, 2021 - 2033 (USD Million)
4.6. Hamsters
4.6.1. Hamsters Market, 2021 - 2033 (USD Million)
4.7. Others
4.7.1. Others Market, 2021 - 2033 (USD Million)
Chapter 5. Application Business Analysis
5.1. Animal Model Market: Application Movement Analysis
5.2. Cancer
5.2.1. Cancer Market, 2021 - 2033 (USD Million)
5.3. Immunological Disease
5.3.1. Immunological Disease Market, 2021 - 2033 (USD Million)
5.4. Infectious Disease
5.4.1. Infectious Disease Market, 2021 - 2033 (USD Million)
5.5. Others
5.5.1. Others Market, 2021 - 2033 (USD Million)
Chapter 6. End Use Business Analysis
6.1. Animal Model Market: End Use Movement Analysis
6.2. Pharmaceutical & Biotechnology Companies
6.2.1. Pharmaceutical & Biotechnology Companies Market, 2021 - 2033 (USD Million)
6.3. Academic Research Institute
6.3.1. Academic Research Institute Market, 2021 - 2033 (USD Million)
6.4. Contract Research Organization
6.4.1. Contract Research Organization Market, 2021 - 2033 (USD Million)
Chapter 7. Regional Business Analysis
7.1. Animal Model Market Share By Region, 2024 & 2033
7.2. North America
7.2.1. North America Animal Model Market, 2021 - 2033 (USD Million)
7.2.2. U.S.
7.2.2.1. Key Country Dynamics
7.2.2.2. Competitive Scenario
7.2.2.3. Regulatory Framework
7.2.2.4. U.S. Animal Model Market, 2021 - 2033 (USD Million)
7.2.3. Canada
7.2.3.1. Key Country Dynamics
7.2.3.2. Competitive Scenario
7.2.3.3. Regulatory Framework
7.2.3.4. Canada Animal Model Market, 2021 - 2033 (USD Million)
7.2.4. Mexico
7.2.4.1. Key Country Dynamics
7.2.4.2. Competitive Scenario
7.2.4.3. Regulatory Framework
7.2.4.4. Mexico Animal Model Market, 2021 - 2033 (USD Million)
7.3. Europe
7.3.1. Europe Animal Model Market, 2021 - 2033 (USD Million)
7.3.2. UK
7.3.2.1. Key Country Dynamics
7.3.2.2. Competitive Scenario
7.3.2.3. Regulatory Framework
7.3.2.4. UK Animal Model Market, 2021 - 2033 (USD Million)
7.3.3. Germany
7.3.3.1. Key Country Dynamics
7.3.3.2. Competitive Scenario
7.3.3.3. Regulatory Framework
7.3.3.4. Germany Animal Model Market, 2021 - 2033 (USD Million)
7.3.4. France
7.3.4.1. Key Country Dynamics
7.3.4.2. Competitive Scenario
7.3.4.3. Regulatory Framework
7.3.4.4. France Animal Model Market, 2021 - 2033 (USD Million)
7.3.5. Italy
7.3.5.1. Key Country Dynamics
7.3.5.2. Competitive Scenario
7.3.5.3. Regulatory Framework
7.3.5.4. Italy Animal Model Market, 2021 - 2033 (USD Million)
7.3.6. Spain
7.3.6.1. Key Country Dynamics
7.3.6.2. Competitive Scenario
7.3.6.3. Regulatory Framework
7.3.6.4. Spain Animal Model Market, 2021 - 2033 (USD Million)
7.3.7. Denmark
7.3.7.1. Key Country Dynamics
7.3.7.2. Competitive Scenario
7.3.7.3. Regulatory Framework
7.3.7.4. Denmark Animal Model Market, 2021 - 2033 (USD Million)
7.3.8. Sweden
7.3.8.1. Key Country Dynamics
7.3.8.2. Competitive Scenario
7.3.8.3. Regulatory Framework
7.3.8.4. Sweden Animal Model Market, 2021 - 2033 (USD Million)
7.3.9. Norway
7.3.9.1. Key Country Dynamics
7.3.9.2. Competitive Scenario
7.3.9.3. Regulatory Framework
7.3.9.4. Norway Animal Model Market, 2021 - 2033 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Animal Model Market, 2021 - 2033 (USD Million)
7.4.2. Japan
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. Regulatory Framework
7.4.2.4. Japan Animal Model Market, 2021 - 2033 (USD Million)
7.4.3. China
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Regulatory Framework
7.4.3.4. China Animal Model Market, 2021 - 2033 (USD Million)
7.4.4. India
7.4.4.1. Key Country Dynamics
7.4.4.2. Competitive Scenario
7.4.4.3. Regulatory Framework
7.4.4.4. India Animal Model Market, 2021 - 2033 (USD Million)
7.4.5. Australia
7.4.5.1. Key Country Dynamics
7.4.5.2. Competitive Scenario
7.4.5.3. Regulatory Framework
7.4.5.4. Australia Animal Model Market, 2021 - 2033 (USD Million)
7.4.6. Thailand
7.4.6.1. Key Country Dynamics
7.4.6.2. Competitive Scenario
7.4.6.3. Regulatory Framework
7.4.6.4. Thailand Animal Model Market, 2021 - 2033 (USD Million)
7.4.7. South Korea
7.4.7.1. Key Country Dynamics
7.4.7.2. Competitive Scenario
7.4.7.3. Regulatory Framework
7.4.7.4. South Korea Animal Model Market, 2021 - 2033 (USD Million)
7.5. Latin America
7.5.1. Latin America Animal Model Market, 2021 - 2033 (USD Million)
7.5.2. Brazil
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Regulatory Framework
7.5.2.4. Brazil Animal Model Market, 2021 - 2033 (USD Million)
7.5.3. Argentina
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Framework
7.5.3.4. Argentina Animal Model Market, 2021 - 2033 (USD Million)
7.6. MEA
7.6.1. MEA Animal Model Market, 2021 - 2033 (USD Million)
7.6.2. South Africa
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Framework
7.6.2.4. South Africa Animal Model Market, 2021 - 2033 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Framework
7.6.3.4. Saudi Arabia Animal Model Market, 2021 - 2033 (USD Million)
7.6.4. UAE
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Regulatory Framework
7.6.4.4. UAE Animal Model Market, 2021 - 2033 (USD Million)
7.6.5. Kuwait
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Regulatory Framework
7.6.5.4. Kuwait Animal Model Market, 2021 - 2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Market Share Analysis, 2022
8.4. Company Profiles/Listing
8.4.1. Charles River Laboratories
8.4.1.1. Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. The Jackson Laboratory
8.4.2.1. Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. genOway
8.4.3.1. Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. Taconic Biosciences, Inc
8.4.4.1. Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. Janvier Labs
8.4.5.1. Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. BioModels, LLC.
8.4.6.1. Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. Crown Bioscience
8.4.7.1. Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. Inotiv
8.4.8.1. Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. BIOCYTOGEN
8.4.9.1. Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. Hooke Laboratories
8.4.10.1. Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Strategic Initiatives

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us